Welcome to our dedicated page for Waldencast news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast stock.
Waldencast plc operates as a global multi-brand beauty and wellness platform built around Obagi Medical and Milk Makeup. News about WALD commonly covers brand-level product launches, physician-dispensed skincare, cosmetics, suncare, and aesthetic offerings, including Obagi's advanced skincare products and Obagi® saypha® MagIQ™ hyaluronic acid filler.
Company updates also include quarterly and annual financial results, segment performance, channel and distribution developments, clinical-evidence collaborations for aesthetic products, supply-chain and credit-facility actions, and governance or reporting matters tied to financial restatements, internal control over financial reporting, and regulatory review.
Waldencast Acquisition Corp. (NASDAQ: WALD) received a notice from Nasdaq on May 28, 2021, for failing to timely file its Quarterly Report on Form 10-Q for the quarter ending March 31, 2021. This non-compliance with Nasdaq Listing Rule 5250(c)(1) does not immediately affect its securities listing, which will continue to trade on Nasdaq. WALD has 60 days to file the Form 10-Q or submit a compliance plan. If accepted, Nasdaq may grant up to 180 days for compliance, until November 22, 2021. The Company is also evaluating the accounting treatment of its warrants under recent SEC guidance.
Summary not available.